50 completed, 29 recruiting, 24 unknown, 18 active not recruiting. 148 Phase 2, 27 Phase 1, 2 Phase 3.
Follow Hodgkin Lymphoma: new trials by email Literature Review of Hodgkin Lymphoma trials Research Report on Hodgkin Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2 Trial of CD70.CAR NK Cells for Patients With Primary Refractory or Early Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma Fludarabine, Cyclophosphamide, CD70.CAR NK Cells - Large B-cell Lymphoma, Hodgkin Lymphoma | Phase 2 | Not yet recruiting | M.D. Anderson Cancer Center | 100 | 2026-12-28 | 2026-07-15 |
| Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging - Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8 | Phase 2 | Not yet recruiting | Fred Hutchinson Cancer Center | 50 | 2026-12-01 | 2026-09-17 |
| Phase II Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL Nivolumab, Doxorubicin Hydrochloride, Vinblastine - Hodgkin Lymphoma | Phase 2 | Recruiting | M.D. Anderson Cancer Center | 15 | 2026-08-19 | 2026-08-31 |
| PD-1 Antibody and JAK1 Inhibitor for Newly Diagnosed Pediatric Hodgikin's Lympoma PD-1+JAK1i, PD-1 - Hodgkin Lymphoma | Phase 1 / Phase 2 | Not yet recruiting | Shanghai Jiao Tong University School of Medicine | 112 | 2026-06-30 | 2026-06-11 |
| Cord Blood Transplantation in Children and Young Adults With Blood Cancer Cord Blood Units, Total Body Irradiation, Cyclophosphamide - Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia | Phase 2 | Recruiting | Memorial Sloan Kettering Cancer Center | 71 | 2026-04-28 | 2026-05-14 |
| ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis Cyclophosphamide, Fludarabine, Thiotepa - Acute Myelogenous Leukemia, Acute Lymphatic Leukemia | Phase 2 | Suspended | Leland Metheny | 20 | 2026-04-08 | 2026-09-10 |
| The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas Cancer Therapeutic Procedure, Questionnaire Administration - Amyloidosis, Basal Cell Carcinoma | Phase 2 | Recruiting | Mayo Clinic | 27 | 2025-12-18 | 2026-09-30 |
| Mozobil for Autologous Hematopoietic Stem Cell Transplantation Plerixafor, Gcsf - Multiple Myeloma, Hodgkin Lymphoma | Phase 2 | Suspended | Thomas Jefferson University | 100 | 2025-10-16 | 2026-11-18 |
| Pembrolizumab in First-Line Treatment of Advanced-Stage Classical Hodgkin Lymphoma Pembrolizumab - Hodgkin Lymphoma | Phase 2 | Not yet recruiting | University of Cologne | 40 | 2025-08-01 | 2025-04-06 |
| PET-Adapted First-Line Therapy With Nivolumab for Advanced Hodgkin Lymphoma Nivolumab, N-EACOPD-14, N-AVD - Hodgkin Lymphoma, Hodgkin Disease | Phase 2 | Recruiting | National Research Center for Hematology, Russia | 30 | 2025-07-29 | 2025-10-06 |
| BrECADD Therapy in Stage 2 B-IV Hodgkin Lymphoma Brentuximab Vedotin, Etoposide, Cyclophosphamide - Hodgkin Lymphoma, Advanced Hodgkin Lymphoma | Phase 2 | Recruiting | University of Miami | 48 | 2025-07-15 | 2026-11-18 |
| A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma VI-0609, BiCNU - Lymphoma, Non-Hodgkin Lymphoma | Phase 2 | Recruiting | VIVUS LLC | 49 | 2025-03-12 | 2026-03-27 |
| A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer Cobolimab, Dostarlimab - Melanoma, Hodgkin Lymphoma | Phase 1 / Phase 2 | Active not recruiting | GlaxoSmithKline | 83 | 2025-03-06 | 2025-11-12 |
| Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial Riluzole, Placebo - Breast Cancer, Sarcoma | Phase 2 | Recruiting | University of California, Irvine | 75 | 2024-12-02 | 2026-07-14 |
| Comparison of AVD + Low-Dose Nivolumab vs. PET-Adapted BEACOPP-like in Advanced cHL Nivo-AVD, BEACOPP-like - Hodgkin Lymphoma | Phase 2 | Recruiting | St. Petersburg State Pavlov Medical University | 178 | 2024-10-14 | 2026-04-01 |
| CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant Allogeneic Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Granulocyte Colony-Stimulating Factor - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | Phase 2 | Recruiting | City of Hope Medical Center | 216 | 2024-07-09 | 2026-10-23 |
| PTCy and ATG for MSD and MUD Transplants ATG 5.0, Cyclophosphamide injection, ATG 4.0 - Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | Recruiting | Instituto Nacional de Cancer, Brazil | 50 | 2024-06-14 | 2025-02-25 |
| Efficacy and Safety of Frontline Tislelizumab in Patients With de Novo Hodgkin Lymphoma Unsuitable for Standard Frontline Chemotherapy Tislelizumab - Hodgkin Lymphoma | Phase 2 | Recruiting | Fondazione Italiana Linfomi - ETS | 28 | 2024-05-23 | 2026-08-19 |
| ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells Chemotherapy, Cell infusion - Hodgkin Lymphoma, Relapse | Phase 1 / Phase 2 | Recruiting | UNC Lineberger Comprehensive Cancer Center | 31 | 2024-04-25 | 2026-08-06 |
| A Study of BV-AVD in People With Bulky Hodgkin Lymphoma Brentuximab vedotin, Doxorubicin, Vinblastine - Hodgkin Lymphoma | Phase 2 | Recruiting | Memorial Sloan Kettering Cancer Center | 71 | 2024-04-17 | 2026-04-23 |
Showing 20 of 148. Sign in to see all of them.
Hodgkin Disease (148) · Lymphoma, Non-Hodgkin (42) · Myelodysplastic Syndromes (32) · Leukemia, Myeloid, Acute (26) · Leukemia, Lymphocytic, Chronic, B-Cell (24) · Multiple Myeloma (23) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (21) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (20) · Lymphoma, Mantle-Cell (15) · Myeloproliferative Disorders (15) · Lymphoma (13) · Lymphoma, Follicular (13) · Lymphoma, Large B-Cell, Diffuse (12) · Burkitt Lymphoma (10) · Leukemia (9)
Immune System Diseases (148) · Immunoproliferative Disorders (148) · Hemic and Lymphatic Diseases (147) · Lymphatic Diseases (147) · Lymphoproliferative Disorders (147) · Neoplasms by Histologic Type (147) · Neoplasms (145) · Lymphoma (135) · Hematologic Diseases (46) · Pathological Conditions, Signs and Symptoms (42) · Pathologic Processes (41) · Disease Attributes (40) · Bone Marrow Diseases (36) · Leukemia, Lymphoid (34) · Chronic Disease (32)
Cyclophosphamide (32) · Brentuximab Vedotin (24) · Nivolumab (22) · Doxorubicin (19) · Mycophenolic Acid (19) · Whole-Body Irradiation (18) · fludarabine (16) · pembrolizumab (16) · Dacarbazine (14) · Etoposide (12) · Vinblastine (12) · fludarabine phosphate (12) · Granulocyte Colony-Stimulating Factor (11) · Melphalan (11) · Tacrolimus (10)
Memorial Sloan Kettering Cancer Center (10) · M.D. Anderson Cancer Center (7) · St. Jude Children's Research Hospital (6) · University of Cologne (6) · City of Hope Medical Center (5) · St. Petersburg State Pavlov Medical University (5) · Chinese PLA General Hospital (4) · Fondazione Italiana Linfomi - ETS (4) · Masonic Cancer Center, University of Minnesota (4) · Fred Hutchinson Cancer Center (3) · Massachusetts General Hospital (3) · Merck Sharp & Dohme LLC (3) · New York Medical College (3) · Seagen Inc. (3) · The Lymphoma Academic Research Organisation (3)
United States (91) · Italy (14) · China (13) · France (10) · Germany (9) · Russia (8) · Spain (7) · Australia (6) · Belgium (6) · United Kingdom (6) · Canada (5) · Israel (5) · Brazil (4) · Czechia (4) · Poland (4)
Alison Moskowitz, MD (4) · Peter Borchmann, Prof. (4) · Anas Younes, MD (2) · Arnon Nagler, MD (2) · Brandon Triplett, MD (2) · Graham Collins (2) · Jeremy Abramson, MD (2) · Mitchell Cairo, MD (2) · Natalia Mikhailova, MD (2) · Ryotaro Nakamura, MD (2) · Usama Gergis, MD (2) · Alessandro Levis, PhD (1) · Alexander Kulagin, MD,PhD (1)
PMID 40135712, PMID 12377653, PMID 21841163, PMID 22735430, PMID 24573552, PMID 25482239, PMID 27269947, PMID 27760761, PMID 28327905, PMID 28441111, PMID 29141948, PMID 29229594, PMID 29276022, PMID 29360414, PMID 29774169, PMID 30952672, PMID 31012356, PMID 31039052, PMID 31186274, PMID 31395089, PMID 31409671, PMID 31471376, PMID 31917843, PMID 32040960, PMID 32946355, PMID 33062947, PMID 33171487, PMID 33674274, PMID 33820822, PMID 33827139, PMID 34156440, PMID 34327561, PMID 34568066, PMID 34670169, PMID 35848865, PMID 35867960, PMID 36053786, PMID 36399518, PMID 36409612, PMID 37130682, PMID 37319432, PMID 37319435, PMID 37505794, PMID 38454451, PMID 38517235, PMID 39093981, PMID 39319495, PMID 39620432, PMID 39622165, PMID 39661923
2017 (4), 2023 (3), 2014 (2), 2018 (2), 2005 (1), P01CA049605 (1), P01CA078902 (1), P30CA015704 (1), P30CA033572 (1), P30CA138292 (1), R01CA077544 (1), R01CA266783 (1)